Skip to main content
O

Oest

Oest provides a data‑driven, personalized nutraceutical platform for menopause, using an online symptom questionnaire to generate custom oral supplements and targeted topical or protein products from a library of clinically validated ingredients. The products are manufactured under GMP standards and sold direct‑to‑consumer with optional subscription‑based refill plans, offering women 40+ a science‑backed complement to hormone‑replacement therapy.

Updated 2 months ago

Funding

Funding not disclosed

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Women over 40 experience a heterogeneous set of menopause‑related symptoms—hot flashes, sleep disruption, vaginal dryness, loss of muscle mass, and reduced vitality—but most over‑the‑counter products are one‑size‑fits‑all and do not address the individual symptom profile.

Solution

Oest delivers a data‑driven, personalized care platform for menopause. Customers complete an online symptom questionnaire, which feeds an algorithmic formulation engine that selects from thousands of evidence‑based ingredient combinations to create a custom supplement (Oest Única). The product line extends to targeted topical and nutritional solutions—vegan intimate foam, hydrating oil, and a whey‑creatine‑collagen protein blend—each formulated to mitigate specific physiological changes such as elevated vaginal pH, tissue dryness, and sarcopenia. All formulations are developed by qualified physicians and pharmacists, comply with GMP standards, and can be purchased individually or as part of subscription‑enabled kits that auto‑replenish on a regular schedule. The platform also positions the supplement as a complementary option for users already on hormone‑replacement therapy.

Target Audience

Primary customers are women aged 40 + experiencing menopause‑related symptoms, including those who are on hormone‑replacement therapy and seek complementary, science‑backed nutraceutical solutions.

Features

  • Adaptive questionnaire‑to‑formula pipeline that generates a unique supplement composition from a library of clinically validated ingredients.
  • Oest Única: 100 % personalized oral supplement, manufactured under GMP, with ingredient ratios optimized for the user’s reported symptom cluster.
  • Oest Espuma (150 ml): vegan, paraben‑free foam containing hyaluronic acid and essential oils; pH‑balancing, dermatologically tested for gentle intimate cleansing and deep hydration.
  • Oest Hidrata (45 ml): oil blend of coconut, avocado, lavender, copaíba, andiroba, and buriti delivering anti‑inflammatory, antimicrobial, and antioxidant protection to the vaginal mucosa.
  • Oest Forte (440 g): “three‑in‑one” protein matrix combining whey, creatine, BODYBALANCE® collagen, magnesium, and vitamin B6 to support muscle preservation, bone density, and energy metabolism.
  • Oest 360 kits: bundled protocol that synchronizes systemic (Forte) and local (Espuma + Hidrata) interventions for a comprehensive menopause management regimen.
  • Direct‑to‑consumer e‑commerce with optional subscription model for automated refill cycles and discounted pricing.
  • Cloud‑based analytics dashboard for users to track supplement adherence and symptom trends over time.
This profile is AI-generated and may contain inaccuracies.